Adeela Kamal

6.0k total citations · 2 hit papers
49 papers, 4.7k citations indexed

About

Adeela Kamal is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Adeela Kamal has authored 49 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Cell Biology and 9 papers in Immunology. Recurrent topics in Adeela Kamal's work include Heat shock proteins research (18 papers), Cellular transport and secretion (8 papers) and Microtubule and mitosis dynamics (5 papers). Adeela Kamal is often cited by papers focused on Heat shock proteins research (18 papers), Cellular transport and secretion (8 papers) and Microtubule and mitosis dynamics (5 papers). Adeela Kamal collaborates with scholars based in United States, Pakistan and Switzerland. Adeela Kamal's co-authors include Francis Burrows, Lawrence S.B. Goldstein, Marcus F. Boehm, John Sensintaffar, Lin Zhang, Lawrence C. Fritz, Elizabeth A. Roberts, Angels Almenar‐Queralt, James F. LeBlanc and Chun‐hong Xia and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Adeela Kamal

47 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

2003 1.1k citations Adeela Kamal, John Sensintaffar et al. Nature profile →
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins

2007 507 citations Chad A. Dickey, Adeela Kamal et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Adeela Kamal

Since Specialization

Citations

This map shows the geographic impact of Adeela Kamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adeela Kamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adeela Kamal more than expected).

Fields of papers citing papers by Adeela Kamal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adeela Kamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adeela Kamal. The network helps show where Adeela Kamal may publish in the future.

Co-authorship network of co-authors of Adeela Kamal

This figure shows the co-authorship network connecting the top 25 collaborators of Adeela Kamal. A scholar is included among the top collaborators of Adeela Kamal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adeela Kamal. Adeela Kamal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma 2025 ·Pigment Cell & Melanoma Research ·(unknown), (unknown), Mark P. Johnson, Hubert Rehrauer, (unknown), Julia M. Martínez Gómez, (unknown), Adeela Kamal, Reinhard Dummer, Mitchell P. Levesque, Ossia M. Eichhoff	0
2	Additive effect of simultaneous continuous administration of degarelix and TAK-448 on LH suppression in a castrated rat model 2018 ·European Journal of Pharmacology ·(unknown), Diane M. Hargrove, (unknown), Trudy A. Kohout, Adeela Kamal	1
3	Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4 2014 ·PLoS ONE ·(unknown), Christine Mione Kiefer, Adeela Kamal	10
4	BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90 2009 ·Molecular Cancer Therapeutics ·Karen Lundgren, Hong Zhang, (unknown), Nanni Huser, (unknown), (unknown), David J. Busch, Laura Neely, John Sensintaffar, (unknown), (unknown), Jessica Friedman, Robert H. Scannevin, Adeela Kamal, Kevin Hong, Srinivas Rao Kasibhatla, Marcus F. Boehm, Francis Burrows	140
5	Pharmacological induction of the heat shock response improves myelination in a neuropathic model 2008 ·Neurobiology of Disease ·Sunitha Rangaraju, Irina Madorsky, (unknown), Adeela Kamal, Lucia Notterpek	46
6	The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins breakdown → 2007 ·Journal of Clinical Investigation ·Chad A. Dickey, Adeela Kamal, Karen Lundgren, (unknown), Rachel M. Bailey, Judith Dunmore, Peter E.A. Ash, (unknown), Jelena Zlatković, Christopher B. Eckman, Cam Patterson, Dennis W. Dickson, N. Stanley Nahman, Michael Hutton, Francis Burrows, Leonard Petrucelli	507
7	CNF2024 - The first clinical stage synthetic oral Hsp90 inhibitor 2006 ·Cancer Research ·Karen Lundgren, Adeela Kamal, Rachel Lough, (unknown), John Sensintaffar, Cindy Yang, Hong Zhang, Gregg Timony, Kevin Hong, Srinivas Rao Kasibhatla, Marcus F. Boehm, Francis Burrows	1
8	The heat‐shock protein 90 inhibitor 17‐allylamino‐17‐demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis 2006 ·Journal of Neurochemistry ·Cinzia Dello Russo, Paul Polak, (unknown), Alessandra Spagnolo, Anthony Sharp, Patricia Murphy, Adeela Kamal, Francis Burrows, Lawrence C. Fritz, Douglas L. Feinstein	63
9	Development of a High Throughput Drug Screening Assay for the Detection of Changes in Tau Levels - Proof of Concept with HSP90 inhibitors 2005 ·Current Alzheimer Research ·Chad A. Dickey, Jason L. Eriksen, Adeela Kamal, Francis Burrows, Srinivas Rao Kasibhatla, Christopher B. Eckman, Mike Hutton, Leonard Petrucelli	55
10	A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors 2004 ·Cancer Research ·Adeela Kamal, John Sensintaffar, (unknown), Lin Zhang, Marcus F. Boehm, Lawrence C. Fritz, Francis Burrows	28
11	Synthesis and Biological Evaluation of a New Class of Geldanamycin Derivatives as Potent Inhibitors of Hsp90 2004 ·Journal of Medicinal Chemistry ·(unknown), Adeela Kamal, David J. Busch, (unknown), Lin Zhang, Gregg Timony, (unknown), Katy Trent, Rachel Lough, (unknown), Samina Y. Khan, Francis Burrows, Marcus F. Boehm	68
12	Therapeutic and diagnostic implications of Hsp90 activation 2004 ·Trends in Molecular Medicine ·Adeela Kamal, Marcus F. Boehm, Francis Burrows	227
13	Hsp90 Activation and Cell Cycle Regulation 2004 ·Cell Cycle ·Francis Burrows, Hong Zhang, Adeela Kamal	131
14	A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors breakdown → 2003 ·Nature ·Adeela Kamal, (unknown), John Sensintaffar, Lin Zhang, Marcus F. Boehm, Lawrence C. Fritz, Francis Burrows	1121
15	Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP 2001 ·Nature ·Adeela Kamal, Angels Almenar‐Queralt, James F. LeBlanc, Elizabeth A. Roberts, Lawrence S.B. Goldstein	474
16	Kinesin-Dependent Axonal Transport Is Mediated by the Sunday Driver (SYD) Protein 2000 ·Cell ·Aaron B. Bowman, Adeela Kamal, Bruce W. Ritchings, Alastair Valentine Philp, Maura McGrail, Joseph G. Gindhart, Lawrence S.B. Goldstein	268
17	Connecting vesicle transport to the cytoskeleton 2000 ·Current Opinion in Cell Biology ·Adeela Kamal, Lawrence S.B. Goldstein	103
18	Axonal Transport of Amyloid Precursor Protein Is Mediated by Direct Binding to the Kinesin Light Chain Subunit of Kinesin-I 2000 ·Neuron ·Adeela Kamal, Gorazd B. Stokin, (unknown), Chun‐hong Xia, Lawrence S.B. Goldstein	439
19	A Requirement for Ankyrin Binding to Clathrin during Coated Pit Budding 1999 ·Journal of Biological Chemistry ·Peter Michaely, Adeela Kamal, Richard G.W. Anderson, Vann Bennett	47
20	Studies in the biochemistry of microorganisms part 24 structure and stereochemistry of taji xanthone a metabolic product of aspergillus stellatus 1971 ·Pakistan journal of scientific and industrial research ·Adeela Kamal, (unknown), Asaf A. Qureshi	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact